[1]
2024. Prevalence of JAK2 V617F mutation in BCR::ABL negative classical myeloproliferative neoplasm along with a comparison of two mutant allele burden detection techniques. International Archives of BioMedical and Clinical Research. 10, 1 (Mar. 2024), PA5-PA9. DOI:https://doi.org/10.21276/bb6g4y37.